In a recent development, the Supreme Court of India has reprimanded Patanjali Ayurveda, founded by Baba Ramdev, for its misleading advertisements and issued a strict directive to halt such practices immediately. The apex court has taken a tough stance, warning that false claims will incur a hefty penalty of ₹1 crore on each product.
Background:
The Supreme Court addressed petitions filed by the Indian Medical Association (IMA), expressing concerns over Patanjali’s advertising practices. The court, comprising Justices Ahsanuddin Amanullah and Prashant Kumar Mishra, emphasized the need to curb misleading medical advertisements without turning it into an “Allopathy v. Ayurveda” debate.
Key Points from the Court:
Cease Misleading Advertisements: The Supreme Court has unequivocally directed Patanjali Ayurveda to halt all false and misleading advertisements promptly.
Imposition of Heavy Penalty: The court has warned of imposing a substantial cost of ₹1 crore on each product that makes false claims about curing specific diseases.
Serious Examination of the Issue: Justices Amanullah and Mishra emphasized their commitment to addressing the issue seriously and sought viable solutions to combat misleading medical advertisements.
Government Intervention: The Union Government has been tasked with finding effective recommendations to tackle the problem. The court expects suitable measures after consultations, and the matter will be reconsidered on February 5, 2024.
Patanjali’s Alleged Actions: The Indian Medical Association, in its petition, accused Patanjali of spreading false rumors about COVID-19 vaccines, contributing to vaccine hesitancy, and Swami Ramdev’s alleged mockery of citizens searching for oxygen cylinders during the second wave.
Controversial Statements: Baba Ramdev’s controversial statement in February claiming an increase in cancer cases in India after the COVID-19 pandemic has also been highlighted. Criminal cases were filed against Ramdev, who later sought protection from the Supreme Court.
Conclusion:
The Supreme Court’s stern warning to Patanjali Ayurveda underscores the gravity of misleading medical advertisements. As the court takes a firm stance on false claims, the future implications and the government’s proposed recommendations will play a crucial role in addressing this pressing issue. The court’s commitment to finding a real solution reflects a broader effort to maintain the integrity of medical information and protect the public from misinformation.